Plain-English translation of NCT07770841 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This research study is testing , a daily oral medication, to see how well it helps adults with overweight or obesity lose weight. You would take the medication at a lower dose alongside your own efforts to eat less and move more. The study will compare how much weight people lose when taking the medication versus a placebo (a dummy pill with no active ingredient).
Weight loss medications can be helpful for people who have tried dieting on their own without success. This study is looking for the right lower dose of this medication that works well and is safe, so doctors can offer patients more options for managing their weight.
You likely qualify if…
You likely don't qualify if…
You would take one of two doses of the medication (or placebo) by mouth once daily, while also making changes to your diet and exercise habits. Throughout the study, you would attend visits so researchers can check your weight, overall health, and how well the medication is working and if you're experiencing any side effects. The study helps identify which lower dose of the medication is most effective and safest for people with excess weight.
AI-generated summary from trial data · Aug 24, 2026 · Not medical advice
United States